Genesis Vision, Inc.

Genesis Vision, Inc., a minority-owned, small disadvantaged business based in Rochester, New York, manufactures and supplies ophthalmic products — eyeglass frames, lenses, and vision care supplies — to the federal government as a prime contractor on delivery orders and indefinite delivery contracts with the Defense Logistics Agency, competing in full-and-open procurement without set-aside restrictions. The company is an Asian-Pacific American-owned, self-certified small disadvantaged business operating as a for-profit entity; it holds one subsidiary, Vision Associates of Rochester, Inc., also minority-owned and small disadvantaged.

Genesis Vision's federal footprint centers almost entirely on optical lens and frame supply to military and veteran populations. The vendor holds a single-award indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical awarded January 26, 2026, with a ceiling of $41.25 million and an ultimate completion date of January 25, 2031, covering single-vision, bifocal, trifocal, and progressive adaptive lenses in plastic, hard resin, and CR39 materials with optional coatings. Against this IDC and multiple historical IDCs with DLA, Genesis Vision has received a sustained volume of delivery orders — 6,909 task orders under IDC SPE2DE21D0015 alone ($27.2 million combined potential value), 6,480 under SPE2DE20D0013 ($37.3 million), and 5,693 under SPE2DE16D0020 ($14.9 million). Recent representative orders include a $48.9 million delivery order for nylon R-5A eyeglass frames (52-20-145) issued July 2, 2026, a $70.7 million order for nylon R-5A frames (54-20-145) issued June 29, 2026, and a $62.5 million order for plano polycarbonate lenses issued June 17, 2026. Pricing across the portfolio uses fixed-price structures with economic price adjustment; all recent awards carry no set-aside designation.

Customer concentration is extreme and singular. DLA Troop Support Medical accounts for 35,123 of 35,143 total awards (100% of coverage by count) and $1.41 billion of combined potential value across Genesis Vision's federal portfolio. Four other customer agencies — the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 (7 awards, $32.8 million), Veterans Integrated Service Network 20 (3 awards, $6.2 million), the Department of the Army Medical Command (2 awards, $68 thousand), and VA as a standalone entity (1 award, $360 thousand) — account for all remaining activity but represent marginal exposure relative to DLA's dominance.

Activity has been high and sustained. Genesis Vision generated 3,301 awards in 2024, 2,835 in 2023, and 2,431 in 2022, declining to 2,635 in 2025 and 1,227 in 2026 year-to-date (through mid-July). Combined potential value across the portfolio reaches $1.54 billion, though only $169.2 million (11%) has been obligated; the gap reflects the indefinite-delivery structure and the prevalence of large ceiling values spread across many individual delivery orders. The vendor has received awards continuously since at least 2006.

Primary NAICS coding reflects the optical manufacturing and distribution footprint: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (34,238 awards), with minor exposure in Ophthalmic Goods Manufacturing (20 awards). Product Service Code concentration centers on Laboratory Equipment and Supplies (31,384 awards) and Medical and Surgical Instruments, Equipment, and Supplies (3,671 awards). Genesis Vision competes in full-and-open procurement exclusively; no set-aside awards appear in the source data.